EUVIMEDEUVIMED entdecken
Open Access

Heparanase 2 Modulates Vascular Permeability via Heparan Sulfate–Dependent Growth Factor Signaling

Yannic Becker iD, Sergey Tkachuk, Anne Jörns iD, Nelli Shushakova iD, Song Rong iD, Ahmad Alwakaa iD, Jan Hegermann iD, Heiko Schenk iD, Yulia Kiyan, Hermann Haller

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.125.323060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Yannic Becker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hannover Medical School, Germany (Y.B., S.T., N.S., S.R., A.A., H.S., Y.K., H.H.). Hauptthemen laut MEDLINE: Capillary Permeability, Glucuronidase, Zebrafish Proteins, Heparan Sulfate. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Vessel-lining endothelial cells (ECs) rely on heparan sulfate (HS) proteoglycans to regulate vascular permeability and to maintain vascular homeostasis. Hpa2 (heparanase 2) is a little-known, nonenzymatic, HS-binding protein. We hypothesized major functions and thus characterized the role of endogenous Hpa2 in the vertebrate vascular system. METHODS: We use zebrafish larvae as our primary animal model. Hpa2 loss-of-function (LOF) was induced by CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat–associated 9) and morpholino antisense strategies. We assessed vascular permeability, blood vessel architecture, and EC morphology using transgenic zebrafish and transmission electron microscopy. rHpa2 (recombinant heparanase 2) was generated to study the functionality of Hpa2 in endothelial tissue cultures, zebrafish, and mice. RESULTS: We detected Hpa2 expression in hepatic tissue and localized Hpa2 protein in the vasculature of zebrafish and mammals. Hpa2 LOF increased zebrafish vascular permeability and altered EC and extracellular matrix morphology. rHpa2 rescued the Hpa2 LOF phenotype. Hpa2 LOF reduced HS levels and caused EC gene expression changes involved in signal transduction. rHpa2 competed with growth factors FGF2 (fibroblast growth factor-2) and VEGFA 165 (vascular endothelial growth factor A 165 ) for binding on the EC surface and consequently reduced the signal response these factors elicit. rHpa2 prevented VEGFA 165 -induced vascular permeability in murine ex vivo kidneys. Pharmacological inhibition of FGF2/VEGFR (VEGF receptor) signaling alleviated the Hpa2 LOF phenotype in zebrafish. CONCLUSIONS: We suggest that Hpa2 is a circulating molecule that maintains vascular integrity by regulating vascular HS-dependent growth factor signaling. Our model outlines Hpa2-related vascular function and could indicate therapeutic utilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capillary PermeabilityGlucuronidaseZebrafish ProteinsHeparan SulfateEndothelial CellsVascular Endothelial Growth Factor AAnimalsZebrafishSignal TransductionAnimals, Genetically ModifiedHumansMiceLiverCells, CulturedHeparanase

Stichwörter der Autor:innen

endothelial cellsheparan sulfate proteoglycansheparanasehomeostasiszebrafish

Substanzen

GlucuronidaseZebrafish ProteinsHeparan SulfateVascular Endothelial Growth Factor AHeparanaseVegfaa protein, zebrafish

Autor:innen und Institutionen

  • Department of Nephrology, Hannover Medical School, Germany (Y.B., S.T., N.S., S.R., A.A., H.S., Y.K., H.H.).
  • Mount Desert Island Biological Laboratory, Bar Harbor, ME (Y.B., A.A., H.S., H.H.).
  • Institute of Clinical Biochemistry, Hannover Medical School, Germany (A.J.).
  • Phenos GmbH, Hannover, Germany (N.S., S.R.).
  • Institute for Functional and Applied Anatomy, Hannover Medical School, Germany (J.H.).

ORCID-Profile: Yannic Becker, Anne Jörns, Nelli Shushakova, Song Rong, Ahmad Alwakaa, Jan Hegermann, Heiko Schenk

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Becker, Y., Tkachuk, S., Jörns, A., Shushakova, N., Rong, S., Alwakaa, A., Hegermann, J., Schenk, H., Kiyan, Y., & Haller, H. (2025). Heparanase 2 Modulates Vascular Permeability via Heparan Sulfate–Dependent Growth Factor Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323060

Vancouver

Becker Y, Tkachuk S, Jörns A, Shushakova N, Rong S, Alwakaa A, et al. Heparanase 2 Modulates Vascular Permeability via Heparan Sulfate–Dependent Growth Factor Signaling. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.125.323060

BibTeX
@article{Becker2025,
  author = {Becker, Yannic and Tkachuk, Sergey and Jörns, Anne and Shushakova, Nelli and Rong, Song and Alwakaa, Ahmad and Hegermann, Jan and Schenk, Heiko and Kiyan, Yulia and Haller, Hermann},
  title = {Heparanase 2 Modulates Vascular Permeability via Heparan Sulfate–Dependent Growth Factor Signaling},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.125.323060}
}
Kostenlos starten →